Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Apr;15(4):5849-5858.
doi: 10.3892/ol.2018.8009. Epub 2018 Feb 9.

Anti-oncogenic activity of Chibby in the development of human nasopharyngeal carcinoma

Affiliations

Anti-oncogenic activity of Chibby in the development of human nasopharyngeal carcinoma

Cheng-Fu Cai et al. Oncol Lett. 2018 Apr.

Abstract

The Wnt/β-catenin pathway serves important roles in cancer development. The expression and function of Chibby (Cby), as a direct antagonist of β-catenin, in nasopharyngeal carcinoma (NPC) has not been fully investigated. The present study revealed that the mRNA and protein expression of Cby was significantly lower in NPC tissue than in the adjacent normal tissue. Low expression of Cby was significantly associated with the tumor and the clinical staging. Furthermore, Cby overexpression inhibited the proliferation of human NPC SUNE1 cells and induced cell cycle arrest. In addition, Cby overexpression also significantly enhanced the susceptibility of SUNE1 cells to apoptosis. These results indicated that Cby might serve as an anti-oncogenic gene in the development of NPC and could represent a potential therapeutic target for the human NPC therapy.

Keywords: Chibby; Wnt/β-catenin; apoptosis; cell cycle; nasopharyngeal carcinoma.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Expression of Cby in the clinical NPC tissues. (A) Scatter graph depicting the relative level of Cby mRNA of NPC tumor tissue (0.0725±0.0061) and adjacent normal tissue (0.0951±0.0509; Student's t-test, *P=0.0219, n=45). (B) The expression of Cby protein in NPC tissue and adjacent normal tissue. Cby expression is clearly observed in the nuclei of adjacent normal tissue cells, but expression is significant lower in NPC cells (original magnification, ×200). Cby, Chibby; NPC, nasopharyngeal cancer; T, NPC tissue; P, adjacent normal tissue.
Figure 2.
Figure 2.
Establish of Cby overexpression SUNE1 cells model. (A and B) Expression of Cby in NP69 and SUNE1 cells detected by western blot analysisfollowing transfection withplv-cs2.0 (empty vector) and plv-cs2.0-Cby. (C) Activation of Wnt signaling assessed by β-catenin/T-cell factor-responsive luciferase reporter activity, normalized to β-Gal. Wnt3a, 30 nM. *P<0.05; **P<0.01; ***P<0.001. Cby, Chibby.
Figure 3.
Figure 3.
Effect of Cby overexpression on the proliferation of SUNE1 cells. (A) The growth of NP69 and SUNE1 cells transfected with plv-cs2.0 (empty vector) or plv-cs2.0-Cby were detected by MTT assay every 24 h from day 0 to day 5. (B) The anti-oncogenic potential of Cby, assessed by colony formation assays. The number of foci containing >50 cells was counted. **P<0.01; ***P<0.001. Cby, Chibby.
Figure 4.
Figure 4.
Effect of Cby overexpression on the cell cycle distributions and apoptosis of SUNE1 cells. (A) Cell cycle analysis was performed by flow cytometry following plasmid transfection. The proportion of G1 phase cells for plv-cs2.0 (empty vector) and plv-cs2.0-Cby groups were 52.5±2.5 and 73.6±3.2%, respectively (P=0.0051). (B) Apoptosis analysis of the control group plv-cs2.0 and plv-cs2.0-Cby SUNE1 cells. Hoechst 33342 staining showed apoptotic cells with condensed chromatin or fragmented nuclei. Magnification, ×200. (C) Assessment of apoptosis of SUNE1 cells using flow cytometry with Annexin V-fluorescein isothiocyanate/phosphoinositide staining following treatment with 20 µM 5-fluorouracil (left) or 30 nM Wnt 3a (right). *P<0.05, **P<0.01. Cby, Chibby.

Similar articles

Cited by

References

    1. Wu VW, Lam YN. Radiation-induced temporo-mandibular joint disorder in post-radiotherapy nasopharyngeal carcinoma patients: Assessment and treatment. J Med RadiatSci. 2016;63:124–132. doi: 10.1002/jmrs.145. - DOI - PMC - PubMed
    1. He YQ, Xue WQ, Shen GP, Tang LL, Zeng YX, Jia WH. Household inhalants exposure and nasopharyngeal carcinoma risk: A large-scale case-control study in Guangdong, China. BMC Cancer. 2015;15:1022. doi: 10.1186/s12885-015-2035-x. - DOI - PMC - PubMed
    1. Ng WT, Choi CW, Lee MC, Chan SH, Yau TK, Lee AW. Familial nasopharyngeal carcinoma in Hong Kong: Epidemiology and implication in screening. Fam Cancer. 2009;8:103–108. doi: 10.1007/s10689-008-9213-9. - DOI - PubMed
    1. Mesic JB, Fletcher GH, Goepfert H. Megavoltage irradiation of epithelial tumors of the nasopharynx. Int J Radiat Oncol Biol Phys. 1981;7:447–453. doi: 10.1016/0360-3016(81)90129-2. - DOI - PubMed
    1. Lee AW, Poon YF, Foo W, Law SC, Cheung FK, Chan DK, Tung SY, Thaw M, Ho JH. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976–1985: Overall survival and patterns of failure. Int J Radiat Oncol Biol Phys. 1992;23:261–270. doi: 10.1016/0360-3016(92)90740-9. - DOI - PubMed